Role of nuclear profilin-1 in DNA replication fork stability and cancer chemotherapy response
核 profilin-1 在 DNA 复制叉稳定性和癌症化疗反应中的作用
基本信息
- 批准号:10587921
- 负责人:
- 金额:$ 39.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Actin-Binding ProteinActinsBindingBreast Cancer CellCamptothecinCell DeathCell NucleusCellsCharacteristicsChemoresistanceChemotherapy-Oncologic ProcedureChromatinChromosome abnormalityClinicalComplexCytoplasmDNADNA DamageDNA MaintenanceDNA RepairDNA biosynthesisDNA lesionDNA replication forkDataEnzymesEquilibriumExcisionExportinsFANCD2 proteinFoundationsFundingGenomic InstabilityGrantHistonesHypersensitivityInvestigationKnowledgeMalignant NeoplasmsMammalian CellMethylationModelingMolecularNamesNatural ImmunityNuclearNucleosomesOncogenesOutcomePhenotypePlayPoly(ADP-ribose) Polymerase InhibitorPolymersPredispositionProcessProlineProteinsPublishingRationalizationRegulationRelaxationReportingRoleSMARCA5 geneSingle-Stranded DNASlideSolidSourceStimulator of Interferon GenesStressStructureTestingTherapeuticTimeTranscription ElongationTumor Suppressor ProteinsUp-RegulationWarWorkanti-canceranticancer activityarmbrca genecancer cellchemotherapycofactorcoping mechanismgenotoxicityhydroxyureainsightmicronucleusnovelnucleasepolymerizationprofilin 1replication stressstemtreatment responsetumortumor growth
项目摘要
PROJECT SUMMARY
DNA replication stress is one of the mechanistic underpinnings of many genotoxic chemotherapies which cause
replication fork stalling. Stalled forks frequently reverse to form four-way junction structures, as a natural coping
mechanism, to allow repair of the DNA lesions ahead of the forks and avoid catastrophic fork collapse. However,
fork reversal is a double-edged sword because the nascent DNA in the reversed arm is susceptible to excessive
nuclease resection if not securely protected which can lead to severe genome instability. Many factors play tug-
of-war at stalled forks to strengthen or weaken their stability, and their balance in the cell determines the fate of
replication forks during stress and cellular outcome upon chemotherapy treatments. In this study, we investigate
the molecular mechanisms of a novel replication fork regulator named profilin-1 (Pfn1). As a well-known actin-
binding protein, Pfn1 plays an essential role in actin polymerization and dynamics. Paradoxically, it also has well-
documented but poorly understood anticancer activities including the ability to sensitize cancer cells to
chemotherapy treatments. In recently published work, we demonstrated for the first time that the anticancer
effects of Pfn1 stem, at least partially, from its nuclear functions that are spatially and mechanistically distinct
from its cytoplasmic function in actin regulation. We showed that nuclear Pfn1 directly interacts with ENL in the
Super Elongation Complex (SEC) and inhibits the ability of SEC to drive transcriptional elongation of various
cancer genes including MYC. We also presented clinical evidence that nuclear Pfn1 level is frequently decreased
in cancer due to the upregulation of its nuclear exporter exportin-6 (XPO6), whose deletion increases nuclear
Pfn1 level and decreases tumor growth. These findings establish the notion that Pfn1 has fundamentally
important and cancer-relevant functions in the nucleus, and set the stage for further discovery of its involvement
in additional nuclear processes. In this grant, we present novel evidence that nuclear Pfn1 promotes normal DNA
replication but causes fork destabilization during stress and increases cellular sensitivity to replication stress-
inducing chemotherapies including PARP inhibitors. We hypothesize that nuclear Pfn1 has context-dependent
effects on DNA replication forks. Under normal conditions, it promotes fork progression by increasing chromatin
relaxation through SNF2H. Under stressed conditions, it promotes fork reversal by stimulating SNF2H and
increases fork resection by suppressing BOD1L, leading to fork destabilization. Aim 1: Determine the effect of
nuclear Pfn1 on BOD1L-dependent replication fork protection. Aim 2: Define the role of Pfn1/SNF2H axis in
replication fork remodeling and stability. Aim 3: Understand the chemotherapy-sensitizing ability of nuclear Pfn1.
Work proposed in this grant has the potential to generate important mechanistic insights and proof-of-concept
therapeutic data rationalizing further investigation of nuclear Pfn1 as a synthetic lethal target for genotoxic
chemotherapies.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jieya Shao其他文献
Jieya Shao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jieya Shao', 18)}}的其他基金
pSer784-VCP: a clinically relevant link between autophagy and DNA damage response
pSer784-VCP:自噬和 DNA 损伤反应之间的临床相关联系
- 批准号:
10612443 - 财政年份:2022
- 资助金额:
$ 39.3万 - 项目类别:
pSer784-VCP: a clinically relevant link between autophagy and DNA damage response
pSer784-VCP:自噬和 DNA 损伤反应之间的临床相关联系
- 批准号:
10435173 - 财政年份:2022
- 资助金额:
$ 39.3万 - 项目类别:
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
了解 Profilin-1 的空间调节肿瘤抑制功能及其在乳腺癌中的失调
- 批准号:
10062480 - 财政年份:2016
- 资助金额:
$ 39.3万 - 项目类别:
Understanding Spatially Regulated Tumor-Inhibitory Function of Profilin-1 and its Deregulation in Breast Cancer
了解 Profilin-1 的空间调节肿瘤抑制功能及其在乳腺癌中的失调
- 批准号:
9239553 - 财政年份:2016
- 资助金额:
$ 39.3万 - 项目类别:
相似海外基金
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6338828 - 财政年份:2000
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6107703 - 财政年份:1999
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6271817 - 财政年份:1998
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6240599 - 财政年份:1997
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287441 - 财政年份:1985
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287442 - 财政年份:1985
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287445 - 财政年份:1985
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287439 - 财政年份:1985
- 资助金额:
$ 39.3万 - 项目类别:
STRUCTURE/INTERACTIONS OF ACTINS & ACTIN-BINDING PROTEIN
肌动蛋白的结构/相互作用
- 批准号:
3287443 - 财政年份:1985
- 资助金额:
$ 39.3万 - 项目类别:














{{item.name}}会员




